NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies today announced it has regained compliance to continue listing its shares on the Nasdaq. 

Genetic Technologies received a warning letter from Nasdaq in November 2014 telling the firm it did not meet a listing requirement of at least $2.5 million in stockholder equity. The company said today that it had net assets of about A$21 million (about US$16.5 million) as of March 31, allowing it continue listing its stock on the Nasdaq.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.